Huge Unmet Insulin Demand Attracts Drug Makers to China : Ken Research

1
Huge Unmet Insulin Demand Attracts Drug Makers to
China Ken Research
2

• Diabetes has become a common household in disease
  in China over the past two decades. In fact, the
  prevalence of diabetes in China increased from 1
  per capita in 1980 to over 12 per capita by
  2013. Data reveals that diabetes is about to
  reach catastrophic levels in the near future.
• MORE THAN 150 MILLION EXPECTED TO HAVE DIABETES
  BY 2040
• Though this figure is unexpectedly high, it also
  has some direct impact on the Chinese diabetes
  care market. For instance, the consumption of
  insulin is expected to gain a rapid momentum.
  The insulin market in China showcased a growth
  rate at a CAGR of 18.3 during 2008-2013. This
  indicates tremendous growth opportunities for
  both local Chinese drug manufacturers and
  international drug makers. With such a huge need
  for proper diabetes care, the first step is to
  fulfill the unmet insulin needs, the basis for
  diabetes treatment. While multinational companies
  continue to focus on urban China, the local
  producers are better positioned to promote
  insulin products in the rural areas by building
  better relationships with healthcare
  professionsals.

3

• Players Positioning
• This growing need for diabetes treatment in China
  has attracted several leading players from across
  the globe. Companies such as Novo Nordisk, Eli
  Lilly and Sanofi Aventis capture a large
  proportion of the market, whereas domestic
  players including TonghuaDongbao and Shanghai
  Fosun Pharmaceutical share a small fraction of
  the Chinese insulin market. Talking in terms of
  latest developments, multinational Sanfoi has
  announced plans of setting up joint venture with
  Zhejiang Hisun Pharmaceutical Co. Ltd. for
  developing insulin and other diabetes related
  treatments. Other international giants like Eli
  Lilly and Novo Nordisk have also announced plans
  for developing close ties with governments
  healthcare workers for educating about diabetes.
  In terms of a long term perspective, the
  government has also collaborated with several of
  these leading insulin companies for spreading
  awareness via campaigns and free diagnostic
  services.

4

• The Future For Chinese Insulin Market Looks
  Positive
• The government has awakened and taking rational
  steps to provide better access to medical
  treatment. Not only is it increasing awareness in
  the rural areas, but it is also urging both
  multinational and domestic producers to focus on
  the production of insulin which is the first step
  in meeting the needs of a largely diabetic
  population. Medical insurance, drug supply
  security, medical-service provision and public
  health services are some of the initiatives
  undertaken by the government. The drug
  manufacturing firms are also carrying out
  extensive RD within China to understand the
  local trends and supplying corresponding
  solutions to meet future demand.

5

• To know more about what is happening in the
  Chinas Insulin Market, click on the link
• https//www.kenresearch.com/tag/healthcare/diabete
  s/228.html
•  
• Contact
• Ken Research
• Ankur Gupta, Head Marketing Communications
• query_at_kenresearch.com
• 91-124-4230204

6
Thank you